首页> 外文期刊>Journal of drug targeting >Nasal delivery of antisense oligonucleotides: in vitro evaluation of a thiomer/glutathione microparticulate delivery system.
【24h】

Nasal delivery of antisense oligonucleotides: in vitro evaluation of a thiomer/glutathione microparticulate delivery system.

机译:鼻反义寡核苷酸的递送:硫聚体/谷胱甘肽微粒递送系统的体外评估。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: The aim of this study was to develop a nasal mucoadhesive microparticulate delivery system for phosphorothioate antisense oligonucleotides (PTO-ODNs) utilizing the thiomer technology. METHODS: PTO-ODN microparticles, coated with either the mucoadhesive polymer polycarbophil-cysteine (PCP-Cys) or unmodified PCP and reduced glutathione (GSH) were prepared by the emulsification solvent evaporation technique. Particle size, drug load, decrease in thiol groups on microparticles, swelling properties, release of incorporated PTO-ODN, and mucoadhesive properties were examined. Permeation enhancing effect of the deployed thiomer conjugate was investigated on excised porcine respiratory mucosa of the nasal cavity. RESULTS: Results demonstrated that microparticles were almost of spherical structure displaying particle diameter up to 30 microm. In addition, a controlled drug release of the incorporated PTO-ODN was achieved from these particles. Mucoadhesion studies revealed that thiolated PCP-Cys microparticles display 3-fold higher mucoadhesive properties than the corresponding unthiolated polycarbophil microparticles. The uptake of PTO-ODN, incubated in thiolated polycarbophil and glutathione microparticles, from the nasal mucosa was 2.2-fold improved. CONCLUSIONS: According to these results, the thiolated polycarbophil/reduced GSH microparticles might be a promising formulation for systemic delivery of PTO-ODNs via the nasal route.
机译:目的:本研究的目的是利用硫醇技术开发一种用于硫代磷酸酯反义寡核苷酸(PTO-ODNs)的鼻粘膜粘附微粒递送系统。方法:通过乳化溶剂蒸发技术制备涂有粘膜粘附性聚合物聚卡波非-半胱氨酸(PCP-Cys)或未修饰的PCP和还原型谷胱甘肽(GSH)的PTO-ODN微粒。检查了粒径,药物载量,微粒上硫醇基的减少,溶胀性能,掺入的PTO-ODN的释放以及粘膜粘附性能。研究了已部署的硫代聚合物缀合物对猪鼻腔呼吸道黏膜的渗透增强作用。结果:结果表明,微粒几乎呈球形,粒径最大为30微米。另外,从这些颗粒中实现了掺入的PTO-ODN的受控药物释放。粘膜黏附研究表明,与相应的未巯基化的聚卡波非微粒相比,硫醇化的PCP-Cys微粒显示出3倍更高的粘膜黏附特性。在硫醇化聚卡波非和谷胱甘肽微粒中孵育的PTO-ODN从鼻黏膜的吸收提高了2.2倍。结论:根据这些结果,硫醇化的聚卡波非/还原的谷胱甘肽微粒可能是通过鼻途径全身性递送PTO-ODN的有前途的制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号